Hanekamp Annemarie
SEC insider (Form 3/4/5 filer). CIK 0002118987. Chief Commercial Officer at BioNTech SE (BNTX). 2 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in MAINZ.
Companies Hanekamp Annemarie has filed insider reports for
- BioNTech SE (BNTX): Officer, Chief Commercial Officer
Hanekamp Annemarie
CIK: 0002118987
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNTX
BioNTech SE
Officer